Yi-Kai LoFounder

United States - Los Angeles, California

Yi-Kai Lo, PhD, is a cutting-edge researcher, engineer, and scientist turned innovator. Driven by an entrepreneurial spirit, Dr. Lo discovered that intelligent bioelectronics could provide possible solutions for impossible problems. His unique ability to translate complex neural engineering technology into practical treatment solutions, for patients with limited treatment options, propels the newest tech being developed at ANEUVO. In 2016, he co-founded ANEUVO, a company whose mission is to develop and bring to market advanced technologies and therapies designed to help patients with diseases and injuries that have not responded to conventional medical approaches, dramatically improving their quality of life. ANEUVO will be launching the first multi-center, randomized, controlled pivotal trial, investigating a non-invasive neurostimulation therapy intended to improve and restore motor function for people with paralysis due to spinal cord injury. The study will begin enrollment in early 2023.